🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/12/1979 | 1,91 | 1,92 | 1,90 | 1,90 | -0,17% | 1,04% | 1.478.938 |
| 12/12/1979 | 1,92 | 1,92 | 1,90 | 1,91 | -0,86% | 0,69% | 2.222.179 |
| 11/12/1979 | 1,94 | 1,94 | 1,92 | 1,92 | -1,02% | 1,36% | 2.448.547 |
| 10/12/1979 | 1,95 | 1,95 | 1,91 | 1,94 | -0,51% | 2,04% | 2.154.269 |
| 07/12/1979 | 1,95 | 1,97 | 1,95 | 1,95 | +0,17% | 1,02% | 3.293.654 |
| 06/12/1979 | 1,92 | 1,95 | 1,92 | 1,95 | +1,91% | 1,73% | 2.252.362 |
| 05/12/1979 | 1,92 | 1,93 | 1,91 | 1,91 | -0,34% | 1,38% | 1.622.304 |
| 04/12/1979 | 1,90 | 1,93 | 1,89 | 1,92 | +1,22% | 1,75% | 2.041.085 |
| 03/12/1979 | 1,91 | 1,91 | 1,89 | 1,90 | -1,21% | 0,87% | 1.524.211 |
| 30/11/1979 | 1,94 | 1,94 | 1,92 | 1,92 | -1,36% | 1,03% | 1.901.491 |
| 29/11/1979 | 1,96 | 1,96 | 1,93 | 1,94 | -0,68% | 1,35% | 1.063.930 |
| 28/11/1979 | 1,93 | 1,96 | 1,91 | 1,96 | +1,20% | 2,40% | 1.516.666 |
| 27/11/1979 | 1,94 | 1,96 | 1,93 | 1,93 | -0,17% | 1,54% | 2.033.539 |
| 26/11/1979 | 1,89 | 1,95 | 1,89 | 1,94 | +3,35% | 3,51% | 3.927.485 |
| 23/11/1979 | 1,85 | 1,88 | 1,85 | 1,88 | +1,80% | 1,79% | 2.806.963 |
| 21/11/1979 | 1,83 | 1,85 | 1,78 | 1,84 | +0,54% | 3,62% | 2.701.325 |
| 20/11/1979 | 1,82 | 1,84 | 1,81 | 1,83 | +0,91% | 1,64% | 1.146.931 |
| 19/11/1979 | 1,82 | 1,86 | 1,81 | 1,82 | -0,37% | 2,55% | 1.852.445 |
| 16/11/1979 | 1,84 | 1,87 | 1,82 | 1,82 | -1,07% | 2,33% | 1.614.758 |
| 15/11/1979 | 1,83 | 1,86 | 1,83 | 1,84 | +0,90% | 1,63% | 4.625.453 |
| 14/11/1979 | 1,80 | 1,83 | 1,77 | 1,83 | +1,47% | 3,32% | 2.557.958 |
| 13/11/1979 | 1,81 | 1,81 | 1,79 | 1,80 | -0,91% | 1,10% | 1.177.114 |
| 12/11/1979 | 1,75 | 1,82 | 1,75 | 1,82 | +3,59% | 3,59% | 1.184.659 |
| 09/11/1979 | 1,73 | 1,76 | 1,73 | 1,75 | +1,93% | 1,91% | 1.041.293 |
| 08/11/1979 | 1,73 | 1,76 | 1,72 | 1,72 | -0,39% | 2,69% | 4.112.352 |
| 07/11/1979 | 1,74 | 1,74 | 1,72 | 1,73 | -0,57% | 1,34% | 2.754.144 |
| 06/11/1979 | 1,74 | 1,74 | 1,73 | 1,74 | -0,76% | 0,76% | 1.018.656 |
| 05/11/1979 | 1,76 | 1,76 | 1,73 | 1,75 | -0,75% | 1,32% | 788.515 |
| 02/11/1979 | 1,76 | 1,78 | 1,76 | 1,76 | +0,00% | 1,13% | 946.973 |
| 01/11/1979 | 1,75 | 1,77 | 1,75 | 1,76 | +0,56% | 1,13% | 1.482.710 |